Drugs / Henna
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01751893 | Jun 2017 → May 2018 | hand-foot syndrome | Cyprus University of Technology | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Henna | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01751893 ↗ |
| Known as | Lawsonia inermis | “A randomised controlled feasibility trial to evaluate Lawsonia inermis (henna)'s effect on palmar-plantar erythrodysesthesia induced by capecitabine or pegylated liposomal doxorubicin.” PMID 33626423 ↗ Feb 2021 |
| Route | Topical | “The treatment will include the application of the henna mixture (paste) (40gr natural henna and 40ml of purified water) to the affected areas (feet or/and hands)” NCT01751893 ↗ |